Adjuvant chemotherapy for oesophagogastric cancer with epirubicin, cisplatin and infusional 5-fluorouracil (ECF): a Royal Marsden pilot study.

Previous trials of adjuvant chemotherapy for oesophagogastric cancer have shown only modest or no improvement in survival. However, the regimens used in these studies produce low response rates in patients with advanced disease. ECF is a new regimen which results in higher response rates and may the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamias, A., Cunningham, D., Nicolson, V., Norman, A., Hill, M., Nicolson, M., O'Brien, M., Webb, A., Hill, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033623/
https://www.ncbi.nlm.nih.gov/pubmed/7880742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033623/
https://www.ncbi.nlm.nih.gov/pubmed/7880742

Ejemplares similares